Note 8 - Share-based Compensation |
3 Months Ended |
---|---|
Sep. 30, 2017 | |
Notes to Financial Statements | |
Disclosure of Compensation Related Costs, Share-based Payments [Text Block] |
Note 8. Share-based Compensation:During the quarter ended
September 30, 2017 and 2016, the Company granted 0.6 million and 1.0 million stock options at weighted average grant prices of $114
.60 and $107.60 and weighted average fair values of $20
.47 and $17.98, respectively. During the quarter ended September 30, 2017 and 2016, the Company granted 500 and 64
,931 restricted stock units at a weighted average fair value of $122
.57 and $109.36, respectively. The Company did not grant any shares of restricted stock during the quarter ended September 30, 2017. During the quarter ended September 3
0, 2016, the Company granted 16,653 shares of restricted stock at a grant date fair value of $106.59, respectively.
Stock options for
32
,625 and 22,145 shares of common stock with total intrinsic values of $0.9 million and $0.9 million were exercised during the quarter ended September 30, 2017 and 2016, respectively.Stock-based
compensation expense of
$3
.8 million and $3.2 million was included in selling, general and administrative expenses for the quarter ended September 30, 2017 and 2016, respectively. As of September 30, 2017, there was $32
.5 million of unrecognized compensation cost related to non-vested stock options, non-vested restricted stock units and non-vested restricted stock. The weighted average period over which the compensation cost is expected to be recognized is 2.6 years. |